Blackstone to Provide Johnson & Johnson $750 Million for OLN324 Phase 3 Program
Funds managed by Blackstone Life Sciences agreed to provide $750 million in development funding for the program.
Funds managed by Blackstone Life Sciences agreed to provide $750 million in development funding for the program.